Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1999
Operations: The Company operates 104 outpatient physical and occupational therapy clinics across 29 states. As of the reporting date, the average age of clinics was 3.5 years. The Company utilizes a partnership structure for most clinics, owning general partnership interests (typically 1%) and limited partnership interests (ranging from 59% to 99%).
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 1999 |
Six Months Ended June 30, 1999 |
|---|---|---|
| Net Revenues | $12,548 | $24,072 |
| Net Income | $619 | $1,080 |
| Operating Income | $1,862 | $3,340 |
| Cash Flow from Operations | N/A | $1,822 |
| Cash and Equivalents (Ending) | $2,626 | $2,626 |
| Total Debt (Notes Payable + Convertible Notes) | $8,083 | $8,083 |
| Current Ratio | 5.52:1 | 5.52:1 |
| Debt-to-Equity Ratio | 0.87:1 | 0.87:1 |
Note: Debt includes $8,050 in convertible subordinated notes and $33 in current notes payable.
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 16.4% ($1.74M) for the quarter and 13% ($2.72M) for the six months compared to the prior year periods. Approximately 61-66% of this growth was attributed to 20 new clinics opened after June 30, 1998.
- Profitability: Net income rose 18.6% ($97k) for the quarter and 9% ($89k) for the six months. Operating margins remained stable, with clinic operating costs as a percentage of net patient revenues holding at 74-75%.
- Cash Position: Cash and cash equivalents decreased significantly from $6.33M (Dec 31, 1998) to $2.63M (June 30, 1999). This $3.7M decline was primarily driven by a $3.41M share repurchase program, capital expenditures ($963k), and distributions to minority investors ($1.11M).
- Cost Structure: Salaries and related costs increased 14% for the quarter, largely due to new clinic openings. General and administrative costs rose 21% due to corporate expansion and increased legal/professional fees.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue opening new clinics at a pace similar to 1998. They anticipate that new clinics will initially operate at lower margins due to start-up costs but will favorably impact results over the next 3-5 years.
- Medicare Changes: The Company transitioned to a fee-schedule reimbursement methodology under the Balanced Budget Act of 1997 effective January 1, 1999. Management does not anticipate a negative impact on 1999 revenues, believing the new rates will be comparable to the previous cost-reimbursement methodology.
- Year 2000 (Y2K) Contingency: The Company is on schedule to complete Y2K remediation for software and IT infrastructure by October 1999. Estimated total costs are a minimum of $114,000, with $73,000 incurred through June 30, 1999. Risks include potential failures in third-party payor systems.
- Capital Allocation: The Company recently completed a Dutch Auction tender offer, repurchasing 346,000 shares (9.6% of outstanding shares) at $9.75 per share. Management believes existing funds and operating cash flows are sufficient for current needs and development plans.
Investor Verification Checklist
- Share Repurchase Impact: Verify the effect of the $3.4M treasury stock purchase on future liquidity and capital flexibility.
- Medicare Fee Schedule: Monitor actual reimbursement rates under the new fee schedule versus the historical cost-reimbursement model to validate management's revenue assumptions.
- New Clinic Performance: Track the ramp-up period and profitability timeline of the 20 new clinics opened in late 1998 and early 1999.
- Convertible Notes: Review the terms of the $8.05M in 8% Convertible Subordinated Notes (due 2003-2004) and potential dilution if conversion prices are triggered.
- Y2K Readiness: Confirm the completion of Y2K remediation and the status of contingency plans for third-party payor system failures.